Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Research suggests that current ICU protocols and ethical guidelines leave doctors exposed to legal liability if forced to make quick decisions in the event of a second COVID-19 spike.
Salvatore Sinno, Chief Security Architect and Director of Cybersecurity Innovation at Unisys, discusses the importance of fighting misinformation during the COVID-19 pandemic.
Dr Samantha Evans, Lecturer in Employee Relations & Human Resource Management at Kent Business School, discusses whether the COVID-19 lockdown and increase in remote working has caused a problem of annual leave being untaken.
The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
Change management specialists, Impact, explain how remote systems could be the future of how a lot of us work, detailing the benefits of remote working and how COVID-19 has forced this change to happen.
Prior to COVID-19, there was a massive spike in ESG investing, but as the global pandemic's wreaked havoc on global markets. Kerstin Engler, Senior Wealth Manager at Geneva Management Group, looks at how COVID-19 might impact ESG investing in the long term.
Mark Frankish, Data Scientist, SAS UK, discusses how AI and analytics can help to streamline the workload of doctors and medical professionals in the NHS and what needs to be done to implement this technology successfully.
Here, Rob Fotheringham, Director of Fotheringham Associates, explains how pseudonymisation can allow organisations to utilise invaluable data received through the emergency response to COVID-19, to benefit future research and analysis.
